ClinicalTrials.Veeva

Menu

Surveillance of Kaletra in Korean Patients

AbbVie logo

AbbVie

Status

Completed

Conditions

HIV-1 Infection

Study type

Observational

Funder types

Industry

Identifiers

NCT01083173
P11-068

Details and patient eligibility

About

This single-arm, multi-center, Post-Marketing Surveillance study of Kaletra (lopinavir/ritonavir) was conducted in accordance with the approved Korean product labeling in participants 2 years of age and older with human immunodeficiency virus type 1 (HIV-1) infection.

Full description

Participants were observed for up to 48 weeks following the first dose of Kaletra. A follow-up visit took place 1-2 weeks after treatment initiation, and subsequent visits occurred at the discretion of the investigators, typically occurring every 3 months. Clinical/immunological/virological/laboratory status, Kaletra-containing regimen/concomitant medication information, and adverse event information were obtained at follow-up visits.

Enrollment

595 patients

Sex

All

Ages

2 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients 2 years of age and above with HIV-1 infection
  • Patients who were prescribed Kaletra treatment as per investigator's medical judgment
  • Patients who gave verbal or written authorization to use their personal and health data
  • Patients who started Kaletra treatment after study agreement was in place

Exclusion criteria

  • Patients with known hypersensitivity to lopinavir, ritonavir or any excipients of the Kaletra tablet
  • Patients who were being treated or will be treated with drugs that are contraindicated with Kaletra
  • Patients who have been treated with Kaletra
  • Patients participating in other clinical trials

Trial design

595 participants in 1 patient group

Participants with HIV-1 infection
Description:
Participants treated with Kaletra (lopinavir/ritonavir 200 mg/50 mg and 100 mg/25 mg) tablet

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems